Recommended reading

• 

  Subject Recruitment Advertisement for Phase III Clinical Study of Therapeutic (Synthetic Peptide) Hepatitis B Vaccine (NHT210118)

• Novel Peptide Bioscience Co., Ltd. Officially Starts its Phase III Clinical Trial of Project NHT210118